2018 AMSN Convention

212 - NASH (Nonalcoholic Steatohepatitis): The Silent Epidemic

Sep 15, 2018 9:45am ‐ Sep 15, 2018 11:00am


Credits: None available.

Standard: $30.00
Members: $20.00

Description

Review the pathophysiology, natural history, diagnosis, and treatment options for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Continuing Education Instructions and Disclosure Information


Contact hours available until 9/16/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures: There are no disclosures to declare.

Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or corporate sponsorship was received.

Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

Learning Outcome:

After completing this learning activity, the participant will be able to describe the diagnosis and treatment options for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Speaker(s):

  • Darlene Lovasik, MN, RN, CCRN-K, Transplant/Surgery Program Nurse Specialist , UPMC Presbyterian University of Pittsburgh Medical Center

Credits Available


NASH (Nonalcoholic Steatohepatitis): The Silent Epidemic

You must be logged in and own this session in order to post comments.